About Sarcoma
Uncommon or rare tumors represent 22% of all cancer diagnoses.
During the last decade, several specialized organizations such as Rare Cancers Europe, highlighted the need to activate favorable policies that improve the availability and patient access to appropriate information, clinical trials and effective treatments.
Minor cancers still pose multiple challenges, many of which focus on sarcomas.
What is Sarcoma?
Sarcomas are a heterogeneous group of strange cancers that develop in connective tissues. There are approximately 70 subtypes of sarcomas and they can affect any part of the body.
The two main types of sarcomas are:
1. Soft tissue sarcomas (STS)
They represent 84% of sarcomas. They develop in any body support tissue, such as fat, muscle or blood vessels, nerves or joints. They include digestive stromal tumors (known as GISTs), which account for approximately 20% of STS.
2. Bone sarcomas
They represent 14% of sarcomas. Estimates of actual sarcoma numbers are not exact because registration is not mandatory in most countries and regulations are uneven.
